-
Electronic (PDF)
-
Site License
-
Enterprisewide
North America Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Global Markets Direct, January 2009, Pages: 118
North America Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012
Summary
This report is an essential source for in-depth information and data relating to North America neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in North America
Scope
- The report provides neurology devices information broken down into detailed categories in North America.
- Total revenues, products sold and end users.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the neurology devices market in North America.
- Evaluate and compare the attractiveness of the market in the region.
- Identify growth segments and opportunities in each industry sector within the region.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
- Analyze the competitiveness of the market in the region and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the region.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the region.
1 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 14
2.1 What Is This Report About? 14
3 Definitions of Markets Covered in the Report 15
3.1 Neurology Devices 15
3.2 CSF (Cerebro Spinal Fluid) Management 15
3.2.1 Hydrocephalus shunt 15
3.2.2 Intra Cranial Pressure (ICP) Monitors 15
3.3 Interventional Neurology 15
3.3.1 Aneurysm Clips 15
3.3.2 Embolic System 15
3.3.3 Navigational System 16
3.4 Neurostimulation Device 16
3.4.1 Spinal Cord Stimulator (SCS) 16
3.4.2 Deep Brain Stimulator (DBS) 16
3.4.3 Vagus Nerve stimulation (VNS) 16
3.5 Neurosurgical Products (Neuroendoscopes) 17
3.5.1 Neurosurgical Products (Neuroendoscopes) 17
3.6 Radio surgery 17
3.6.1 Cyber Knife Radiosurgery 17
3.6.2 Gamma Knife Radiosurgery 17
4 Neurology Devices in North America 18
4.1 Neurology Devices Cross Country Comparison (2000-2012) 18
4.2 Neurology Devices, North America, Overall Revenues ($ mn), 2000-2012 19
4.3 Neurology Devices, North America, Company Share (2006-2007) 23
5 Neurology Devices In United States 24
5.1 Neurology Devices, United States, Overall Revenues ($ mn), 2000-2012 24
5.2 Neurology Devices, United States, Category Volume (Units), 2000-2012 27
5.3 Neurology Devices, United States, Distribution Share (2006-2007) 29
5.3.1 CSF Management Distribution Share (2006-2007) 29
5.3.2 Interventional Neurology Distribution Share (2006-2007) 29
5.3.3 Neurostimulation Devices Distribution Share (2006-2007) 30
5.3.4 Neurosurgical Products Distribution Share (2006-2007) 30
5.3.5 Radiosurgery Distribution Share (2006-2007) 31
5.4 Neurology Devices, United States, Company Share (2006-2007) 32
5.4.1 Neurology Devices, United States, Company Share (2006-2007) 32
5.4.2 CSF Management, United States, Company Share (2006-2007) 33
5.4.3 Interventional Neurology, United States, Company Share (2006-2007) 34
5.4.4 Neurostimulation Devices, United States, Company Share (2006-2007) 35
5.4.5 Neurosurgical Products, United States, Company Share (2006-2007) 36
5.4.6 Radiosurgery, United States, Company Share (2006-2007) 37
6 Neurology Devices In Canada 38
6.1 Neurology Devices, Canada, Overall Revenues ($ mn), 2000-2012 38
6.2 Neurology Devices, Canada, Category Volume (Units), 2000-2012 41
6.3 Neurology Devices, Canada, Distribution Share (2006-2007) 43
6.3.1 CSF Management Distribution Share (2006-2007) 43
6.3.2 Interventional Neurology Distribution Share (2006-2007) 43
6.3.3 Neurostimulation Devices Distribution Share (2006-2007) 44
6.3.4 Neurosurgical Products Distribution Share (2006-2007) 44
6.3.5 Radiosurgery Distribution Share (2006-2007) 45
6.4 Neurology Devices, Canada, Company Share (2006-2007) 46
6.4.1 Neurology Devices, Canada Company share (2006-2007) 46
6.4.2 CSF Management, Canada, Company Share (2006-2007) 47
6.4.3 Interventional Neurology, Canada, Company Share (2006-2007) 48
6.4.4 Neurostimulation Devices, Canada, Company Share (2006-2007) 49
6.4.5 Neurosurgical Products, Canada, Company Share (2006-2007) 50
7 Boston Scientific Corporation Company Profile 51
7.1 Company Overview 51
7.2 Value Chain Analysis 51
7.2.1 Manufacturing 52
7.2.2 Product Development 52
7.2.3 Sales and Marketing 53
7.3 Boston Scientific Corporation Pipeline Products 54
7.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 54
7.3.2 Boston Scientific Corporation Pipeline Products By Development Stage 55
7.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 56
7.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 57
7.3.5 Boston Scientific Corporation Pipeline Products By News Summary 58
8 ev3 Inc. Company Profile 60
8.1 Company Overview 60
8.2 Value Chain Analysis 60
8.2.1 Manufacturing 61
8.2.2 Product Development 61
8.2.3 Sales and Marketing 61
8.3 ev3 Inc. Pipeline Products 62
8.3.1 ev3 Inc. Pipeline Products by Equipment Type 62
8.3.2 ev3 Inc. Pipeline Products by Development Stage 63
8.3.3 ev3 Inc. Pipeline Products by Therapy Area 63
8.3.4 ev3 Inc. Pipeline Products by Clinical Trials 64
8.3.5 ev3 Inc. Pipeline Products by News Summary 64
9 Medtronic, Inc. Company Profile 65
9.1 Company Overview 65
9.2 Value Chain Analysis 65
9.2.1 Manufacturing 66
9.2.2 Product Development 66
9.2.3 Sales and Marketing 66
9.3 Medtronic, Inc. Pipeline Products 67
9.3.1 Medtronic, Inc. Pipeline Products By Equipment Type 67
9.3.2 Medtronic, Inc. Pipeline Products By Development Stage 68
9.3.3 Medtronic, Inc. Pipeline Products By Therapy Area 70
9.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials 72
9.3.5 Medtronic, Inc. Pipeline Products By News Summary 73
10 Cordis Corporation Company Profile 74
10.1 Company Overview 74
10.2 Cordis Corporation Pipeline Products 74
10.2.1 Cordis Corporation Pipeline Products by Equipment Type 74
10.2.2 Cordis Corporation Pipeline Products by Development Stage 74
10.2.3 Cordis Corporation Pipeline Products by Therapy Area 75
10.2.4 Cordis Corporation Pipeline Products by Clinical Trials 75
10.2.5 Cordis Corporation Pipeline Products by News Summary 75
11 Cyberonics, Inc. Company Profile 76
11.1 Company Overview 76
11.2 Cyberonics, Inc. Pipeline Products 76
11.2.1 Cyberonics, Inc. Pipeline Products by Equipment Type 76
11.2.2 Cyberonics, Inc. Pipeline Products by Development Stage 76
11.2.3 Cyberonics, Inc. Pipeline Products by Therapy Area 76
12 Advanced Neuromodulation Systems, Inc. Company Profile 77
12.1 Company Overview 77
13 B. Braun Melsungen AG Company Profile 78
13.1 Company Overview 78
13.2 Value Chain Analysis 78
13.2.1 Manufacturing 79
13.2.2 Product Development 79
13.2.3 Sales and Marketing 80
13.2.4 B. Braun Melsungen AG Pipeline Products by Equipment Type 81
13.2.5 B. Braun Melsungen AG Pipeline Products by Development Stage 81
13.2.6 B. Braun Melsungen AG Pipeline Products by Therapy Area 81
13.2.7 B. Braun Melsungen AG Pipeline Products by Clinical Trials 81
13.2.8 B. Braun Melsungen AG Pipeline Products by News Summary 81
14 Codman & Shurtleff, Inc. Company Profile 82
14.1 Company Overview 82
15 Accuray Incorporated Company Profile 83
15.1 Company Overview 83
15.2 Value Chain Analysis 83
15.2.1 Manufacturing 84
15.2.2 Product Development 84
15.2.3 Sales and Marketing 84
16 Integra LifeSciences Holdings Corporation Company Profile 86
16.1 Company Overview 86
16.2 Value Chain Analysis 86
16.2.1 Manufacturing 87
16.2.2 Product Development 87
16.2.3 Sales and Marketing 88
17 Cyberkinetics Neurotechnology Systems, Inc. Company Profile 89
17.1 Company Overview 89
17.2 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products 89
17.2.1 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Equipment Type 89
17.2.2 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Development Stage 89
17.2.3 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Therapy Area 90
17.2.4 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By Clinical Trials 90
17.2.5 Cyberkinetics Neurotechnology Systems, Inc. Pipeline Products By News Summary 90
18 DI Medical Company Profile 91
18.1 Company Overview 91
18.1.1 NDI Medical Pipeline Products By Equipment Type 91
18.1.2 NDI Medical Pipeline Products By Development Stage 91
18.1.3 NDI Medical Pipeline Products by Therapy Area 91
19 Medtrode Inc. Company Profile 92
19.1 Company Overview 92
19.2 Medtrode Inc. Pipeline Products 92
19.2.1 Medtrode Inc. Pipeline Products By Equipment Type 92
19.2.2 Medtrode Inc. Pipeline Products By Development Stage 92
19.2.3 Medtrode Inc. Pipeline Products By Therapy Area 92
20 Neuro Kinetics, Inc. Company Profile 93
20.1 Company Overview 93
21 NeuroMetrix, Inc. Company Profile 94
21.1 Company Overview 94
21.1.1 NeuroMetrix, Inc. Pipeline Products By Equipment Type 94
21.1.2 NeuroMetrix, Inc. Pipeline Products By Development Stage 94
21.1.3 NeuroMetrix, Inc. Pipeline Products By Therapy Area 94
22 NeuroPace, Inc. Company Profile 95
22.1 Company Overview 95
22.2 NeuroPace, Inc. Pipeline Products 95
22.2.1 NeuroPace, Inc. Pipeline Products by Equipment Type 95
22.2.2 NeuroPace, Inc. Pipeline Products by Development Stage 95
22.2.3 NeuroPace, Inc. Pipeline Products By Therapy Area 95
22.2.4 NeuroPace, Inc. Pipeline Products By Clinical Trials 95
23 NeuroPro Technologies, Inc. Company Profile 96
23.1 Company Overview 96
23.2 NeuroPro Technologies, Inc. Pipeline Products 96
23.2.1 NeuroPro Technologies, Inc. Pipeline Products By Equipment Type 96
23.2.2 NeuroPro Technologies, Inc. Pipeline Products By Development Stage 96
23.2.3 NeuroPro Technologies, Inc. Pipeline Products By Therapy Area 96
24 Northstar Neuroscience, Inc. Company Profile 97
24.1 Company Overview 97
24.2 Northstar Neuroscience, Inc. Pipeline Products 97
24.2.1 Northstar Neuroscience, Inc. Pipeline Products By Equipment Type 97
24.2.2 Northstar Neuroscience, Inc. Pipeline Products By Development Stage 97
24.2.3 Northstar Neuroscience, Inc. Pipeline Products by Therapy Area 98
24.2.4 Northstar Neuroscience, Inc. Pipeline Products by Clinical Trials 98
24.2.5 Northstar Neuroscience, Inc. Pipeline Products by News Summary 98
25 PhotoThera, Inc. Company Profile 99
25.1 Company Overview 99
25.2 PhotoThera, Inc. Pipeline Products 99
25.2.1 PhotoThera, Inc. Pipeline Products by Equipment Type 99
25.2.2 PhotoThera, Inc. Pipeline Products by Development Stage 99
25.2.3 PhotoThera, Inc. Pipeline Products by Therapy Area 99
25.2.4 PhotoThera, Inc. Pipeline Products by Clinical Trials 99
25.2.5 PhotoThera, Inc. Pipeline Products by News Summary 100
26 Victhom Human Bionics Inc. Company Profile 101
26.1 Company Overview 101
26.2 Victhom Human Bionics Inc. Pipeline Products 101
26.2.1 Victhom Human Bionics Inc. Pipeline Products By Equipment Type 101
26.2.2 Victhom Human Bionics Inc. Pipeline Products By Development Stage 101
26.2.3 Victhom Human Bionics Inc. Pipeline Products By Therapy Area 102
26.2.4 Victhom Human Bionics Inc. Pipeline Products By Clinical Trials 102
26.2.5 Victhom Human Bionics Inc. Pipeline Products By News Summary 102
27 Financial Deals Landscape 103
27.1 Detailed Deal Summary 103
27.1.1 Acquisition 103
27.1.2 Partnerships 106
28 Recent Developments 108
28.1 Product News 108
28.1.1 Dec 24, 2008: Accuray Announces Installation Of 100th Cyberknife System In The US 108
28.1.2 Dec 08, 2008: Data From Pivotal Study Show Medtronic Deep Brain Stimulation Therapy Reduced Seizure Rate In Patients With Severe Epilepsy 108
28.1.3 Nov 06, 2008: Newly Published Data From Long-Term Study Show Neurostimulation Provides Sustained Leg Pain Relief, Improved Quality Of Life And Functional Capacity 109
28.1.4 Oct 30, 2008: Texcel Introduces Innovative Programmable, Implantable Stimulation System For R&D 110
28.1.5 Oct 23, 2008: Neuronetrix Wins Technology Award for System to Diagnose Alzheimer’s Disease 110
28.1.6 Oct 22, 2008: Next Generation CyberKnife System Cuts Prostate Cancer Treatment Times In Half At CyberKnife Centers Of San Diego 110
28.1.7 Oct 20, 2008: Concentric Medical Launches Distal Access Catheter 111
28.1.8 Oct 14, 2008: Northstar Neuroscience Receives FDA Approval For A Clinical Study Of Its Cortical Stimulation System For The Treatment Of Major Depressive Disorder 111
28.1.9 Oct 08, 2008: FDA Clears Neuroneticss NeuroStar TMS Therapy For The Treatment Of Depression 111
28.1.10 Oct 03, 2008: Uroplasty Enrolls First Patients In Urgent PC Clinical Trial 111
28.1.11 Oct 02, 2008: NeuroMetrix Inc Receives FDA 510(k) Clearance For UNIVERSAL Electrodes Used In The Performance Of Nerve Conduction Studies 112
29 APPENDIX 113
29.1 Global Markets Direct Research Methodology 113
29.2 Coverage 114
29.3 Secondary Research 114
29.4 Primary Research 115
29.5 Models 115
29.6 Forecasts 116
29.7 Expert Panels 116
29.8 Currency Conversion 117
29.9 Contact Us 118
29.10 Disclaimer 118
Executive Summary
1.2 List of Figures
Figure 1: Neurology Devices, North America, Cross Country Comparison, Revenues ($ mn), 2000-2012 18
Figure 2: Neurology Devices, North America, Overall Revenues ($ mn), 2000-2012 19
Figure 3: Neurology Devices, North America, Portfolio Analysis, 2000-2012 20
Figure 4: Neurology Devices, North America, Overall Revenues ($ mn), Historic, 2000-2007 21
Figure 5: Neurology Devices, North America, Overall Revenues ($ mn), Forecast, 2007-2012 22
Figure 6: Neurology Devices, North America, Company Share (%), 2007 23
Figure 7: Neurology Devices, United States, Overall Revenues ($ mn), 2000-2012 24
Figure 8: Neurology Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007 25
Figure 9: Neurology Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012 26
Figure 10: Neurology Devices, United States, Company Share (%), 2007 32
Figure 11: CSF Management, United States, Company Share (%), 2007 33
Figure 12: Interventional Neurology, United States, Company Share (%), 2007 34
Figure 13: Neurostimulation Devices, United States, Company Share (%), 2007 35
Figure 14: Neurosurgical Products, United States, Company Share (%), 2007 36
Figure 15: Radiosurgery, United States, Company Share (%), 2007 37
Figure 16: Neurology Devices, Canada, Overall Revenues ($ mn), 2000-2012 38
Figure 17: Neurology Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007 39
Figure 18: Neurology Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012 40
Figure 19: Neurology Devices, Canada Company share (%), 2007 46
Figure 20: CSF Management, Canada, Company Share (%), 2007 47
Figure 21: Interventional Neurology, Canada, Company Share (%), 2007 48
Figure 22: Neurostimulation Devices, Canada, Company Share (%), 2007 49
Figure 23: Neurosurgical Products, Canada, Company Share (%), 2007 50
Figure 24: Boston Scientific Corporation Value Chain Analysis 51
Figure 25: ev3 Inc. Value Chain Analysis 60
Figure 26: Medtronic, Inc. Value Chain Analysis 65
Figure 27: B. Braun Melsungen AG Value Chain Analysis 78
Figure 28: Accuray Incorporated Value Chain Analysis 83
Figure 29: Integra LifeSciences Holdings Corporation Value Chain Analysis 86
Figure 30: Global Markets Direct Methodology 113
Boston Scientific Corporation
ev3 Inc.
Medtronic, Inc.
Cordis Corporation
Cyberonics, Inc.
Advanced Neuromodulation Systems, Inc.
B. Braun Melsungen AG
Codman & Shurtleff, Inc.
Accuray Incorporated
Integra LifeSciences Holdings Corporation
Cyberkinetics Neurotechnology Systems, Inc.
DI Medical
Medtrode Inc.
Neuro Kinetics, Inc.
NeuroMetrix, Inc.
NeuroPace, Inc.
NeuroPro Technologies, Inc.
Northstar Neuroscience, Inc.
PhotoThera, Inc.
Victhom Human Bionics Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
